Gemcitabine Plus Nab-paclitaxel as Switch Maintenance Versus Continuation of Modified FOLFIRINOX as 1st Line Chemotherapy in Patients With Advanced Pancreatic Cancer.
Clinical trial NCT06897644 · RECRUITING
Trial details
- NCT number
- NCT06897644
- Sponsor
- Gruppo Oncologico del Nord-Ovest
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-27
- Primary completion
- 2029-01-01
- Enrollment
- 340
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.